Therapeutic lifestyle change and Adult Treatment Panel III: evidence then and now
- PMID: 12361490
- DOI: 10.1007/s11883-002-0047-x
Therapeutic lifestyle change and Adult Treatment Panel III: evidence then and now
Abstract
The Third Report of the National Cholesterol Education Program's Adult Treatment Panel (ATP III) has an extensive section on nonpharmacologic therapy for those with abnormal blood lipids. ATP III focused on the high-saturated fat atherogenic diet, obesity, and sedentary lifestyle and recommended a program of therapeutic lifestyle change (TLC). This review discusses several issues, including 1) why ATP III changed from the Step I and Step II diets to TLC; 2) the benefits of keeping trans fatty acid intake low and the addition of viscous fiber and plant stanol/sterol esters to reduce low-density lipoprotein cholesterol beyond that seen with the Step II diet; 3) the de-emphasis on total fat and a sharper focus on the kinds of fat ingested in the new guidelines; 4) the endorsement of regular physical activity and weight loss as important first steps in reversing the unwanted metabolic effects of the metabolic syndrome; and 5) the emphasis of health-promoting aspects of the diet that include, among other things, fish and omega-3 fatty acids. At all stages of TLC, ATP III encourages the referral to registered dietitians or other qualified nutritionists for medical nutrition therapy. TLC and the ATP III guidelines should provide guidance to practitioners who wish to get low-density lipoprotein cholesterol to goal (whether or not drugs are used), prevent or treat the metabolic syndrome, and improve the overall health of the patient.
Similar articles
-
Treatment of metabolic syndrome.Expert Rev Cardiovasc Ther. 2004 Mar;2(2):213-28. doi: 10.1586/14779072.2.2.213. Expert Rev Cardiovasc Ther. 2004. PMID: 15151470 Review.
-
Therapeutic lifestyle changes and pharmaceutical care in the treatment of dyslipidemias in adults.J Am Pharm Assoc (2003). 2005 Jul-Aug;45(4):492-9; quiz 500-2. doi: 10.1331/1544345054475595. J Am Pharm Assoc (2003). 2005. PMID: 16128506 Review.
-
Isocaloric substitution of plant sterol-enriched fat spread for carbohydrate-rich foods in a low-fat, fibre-rich diet decreases plasma low-density lipoprotein cholesterol and increases high-density lipoprotein concentrations.Nutr Metab Cardiovasc Dis. 2005 Oct;15(5):337-44. doi: 10.1016/j.numecd.2005.03.002. Epub 2005 Jul 28. Nutr Metab Cardiovasc Dis. 2005. PMID: 16216719 Clinical Trial.
-
The optimal dietary strategy to manage risk associated with various dyslipidemias.Curr Cardiol Rep. 2001 Sep;3(5):391-400. doi: 10.1007/s11886-001-0056-3. Curr Cardiol Rep. 2001. PMID: 11504576 Review.
-
The National Cholesterol Education Program: implications for dietetic practitioners from the Adult Treatment Panel recommendations.J Am Diet Assoc. 1988 Nov;88(11):1401-8, 1411. J Am Diet Assoc. 1988. PMID: 3183260
Cited by
-
TLC: an informatics approach to enable patients to initiate tailored lifestyle conversations with providers at the point of care.AMIA Annu Symp Proc. 2009 Nov 14;2009:364-8. AMIA Annu Symp Proc. 2009. PMID: 20351881 Free PMC article.
-
Nutritional Evaluation of Therapeutic Diets for Cardiovascular Diseases in Hospitals of General Santos City, Philippines: A Comparative Cross-sectional Study.Acta Med Philipp. 2025 Jan 15;59(1):7-17. doi: 10.47895/amp.vi0.8167. eCollection 2025. Acta Med Philipp. 2025. PMID: 39897145 Free PMC article.
-
Uncle Sam's diet sensation: MyPyramid--an overview and commentary.MedGenMed. 2005 Aug 2;7(3):78. MedGenMed. 2005. PMID: 16369304 Free PMC article.
-
Clinical Evaluation of a Novel Tablet Formulation of Traditional Thai Polyherbal Medicine Named Nawametho in Comparison with Its Decoction in the Treatment of Hyperlipidemia.Evid Based Complement Alternat Med. 2022 Aug 3;2022:2530266. doi: 10.1155/2022/2530266. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35966727 Free PMC article.
-
Psychosocial characteristics are associated with adherence to dietary, drugs and physical activity recommendations amongst cardiovascular disease patients in Lebanon.PLoS One. 2023 Oct 24;18(10):e0287844. doi: 10.1371/journal.pone.0287844. eCollection 2023. PLoS One. 2023. PMID: 37874832 Free PMC article.